Abstract
A newly defined human B cell differentiation antigen, designated as BDA, has been defined and partially characterized. BDA is expressed on normal human B cells and lymphocytic leukemia cells at all stages of known differentiation (pre-B cells to plasma cells). It is distinct from DR (Ia-like) determinants and other known B cell surface constituents.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Antibody Specificity
-
Antigens*
-
B-Lymphocytes / immunology*
-
Binding Sites
-
Cattle
-
Complement C3
-
Fluorescent Antibody Technique
-
HLA Antigens
-
Haplorhini
-
Histocompatibility Antigens*
-
Humans
-
Immune Sera / pharmacology
-
Immunoglobulin Fc Fragments
-
Lymphoma, Large B-Cell, Diffuse / immunology*
-
Macaca mulatta
-
Rabbits
-
Receptors, Antigen, B-Cell
Substances
-
Antigens
-
Complement C3
-
HLA Antigens
-
Histocompatibility Antigens
-
Immune Sera
-
Immunoglobulin Fc Fragments
-
Receptors, Antigen, B-Cell